Mostrando 4 resultados de: 4
Filtros aplicados
Objetivos de Desarrollo Sostenible
ODS 10: Reducción de las desigualdades(4)
ODS 3: Salud y bienestar(4)
ODS 9: Industria, innovación e infraestructura(2)
ODS 4: Educación de calidad(1)
ODS 8: Trabajo decente y crecimiento económico(1)
Origen
scopus(4)
Identification and validation of microRNAs that synergize with miR-34a–a basis for combinatorial microRNA therapeutics
ArticleAbstract: Efforts to search for better treatment options for cancer have been a priority, and due to these effPalabras claves:combinatorial therapeutics, miR-34, miR-34a, miRNA therapeutics, Mirna-34, synergismAutores:Esteban A. Orellana, Kasinski A.L., Li C., Lisevick A.Fuentes:scopusMETTL4 is an snRNA m<sup>6</sup>Am methyltransferase that regulates RNA splicing
OtherAbstract:Palabras claves:Autores:Chen H., Esteban A. Orellana, Gregory R.I., Gu L., Guo J., Liu Q., Shen Z., Shi Y., Wang L., Wang Y., Wu H., Xing Y.Fuentes:scopusNew Mechanism for Release of Endosomal Contents: Osmotic Lysis via Nigericin-Mediated K<sup>+</sup>/H<sup>+</sup> Exchange
ArticleAbstract: Although peptides, antibodies/antibody fragments, siRNAs, antisense DNAs, enzymes, and aptamers arePalabras claves:Autores:Bandara N.A., Chelvam V., Esteban A. Orellana, Kanduluru A.K., Kasinski A.L., Low P.S., Rangasamy L., Srinivasarao M., You F.Fuentes:scopusSynthetic Lethality of Wnt Pathway Activation and Asparaginase in Drug-Resistant Acute Leukemias
ArticleAbstract: Resistance to asparaginase, an antileukemic enzyme that depletes asparagine, is a common clinical prPalabras claves:acute leukemia, asparaginase, asparagine, Drug resistance, FBXW7, GSK3, proteasomal degradation, protein ubiquitination, synthetic lethality, Wnt signalingAutores:Bauer D.E., Degar J., Esteban A. Orellana, Gregory R.I., Gutierrez A., Hinze L., Karim S., McGuckin C., Neuberg D.S., Pfirrmann M., Sacher J., Stanulla M., Stegmaier K., Stevenson K.E., Vinjamur D., Wagner F.F.Fuentes:scopus